Exact Mass: 325.07819800000004
Exact Mass Matches: 325.07819800000004
Found 275 metabolites which its exact mass value is equals to given mass value 325.07819800000004,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pancratistatin
Pancratistatin is a citraconoyl group. Pancratistatin is a natural product found in Delphinium denudatum, Hymenocallis speciosa, and other organisms with data available. Pancratistatin is a isoquinoline alkaloid from amaryllis with antineoplastic activity.
N-Glycolylneuraminic acid
N-Glycolylneuraminic acid (Neu5Gc) is a widely expressed sialic acid found in most mammalian cells. Although humans are genetically deficient in producing Neu5Gc, small amounts are present in human cells and biofluids. Humans cannot synthesize Neu5Gc because the human gene CMAH is irreversibly mutated, though it is found in apes. This loss of the CMAH gene was estimated to have occurred two to three million years ago, just before the emergence of the genus Homo. A dietary origin of Neu5Gc was suggested by human volunteer studies. These trace amounts of Neu5Gc were determined to come from the consumption of animals in the human diet (i.e. red meats such as lamb, pork, and beef). Neu5Gc can also be found in dairy products, but to a lesser extent. Neu5Gc is not found in poultry and is found in only trace amounts in fish (Wikipedia). Isolated from beef serum KEIO_ID G062
Flumetsulam
CONFIDENCE standard compound; INTERNAL_ID 304; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6616; ORIGINAL_PRECURSOR_SCAN_NO 6611 CONFIDENCE standard compound; INTERNAL_ID 304; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6586; ORIGINAL_PRECURSOR_SCAN_NO 6583 CONFIDENCE standard compound; INTERNAL_ID 304; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3121; ORIGINAL_PRECURSOR_SCAN_NO 3116 CONFIDENCE standard compound; INTERNAL_ID 304; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6618; ORIGINAL_PRECURSOR_SCAN_NO 6616 CONFIDENCE standard compound; INTERNAL_ID 304; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3120; ORIGINAL_PRECURSOR_SCAN_NO 3118 CONFIDENCE standard compound; INTERNAL_ID 304; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6624; ORIGINAL_PRECURSOR_SCAN_NO 6622 INTERNAL_ID 304; CONFIDENCE standard compound; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6586; ORIGINAL_PRECURSOR_SCAN_NO 6583 CONFIDENCE standard compound; INTERNAL_ID 304; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6574; ORIGINAL_PRECURSOR_SCAN_NO 6571 CONFIDENCE standard compound; INTERNAL_ID 304; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3185; ORIGINAL_PRECURSOR_SCAN_NO 3182 CONFIDENCE standard compound; INTERNAL_ID 304; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6622; ORIGINAL_PRECURSOR_SCAN_NO 6620 CONFIDENCE standard compound; INTERNAL_ID 304; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3111; ORIGINAL_PRECURSOR_SCAN_NO 3109 CONFIDENCE standard compound; INTERNAL_ID 304; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3122; ORIGINAL_PRECURSOR_SCAN_NO 3119 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1057
Midazolam
C18H13ClFN3 (325.07819800000004)
A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH. [PubChem] Midazolam is a schedule IV drug in the United States. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent CONFIDENCE standard compound; EAWAG_UCHEM_ID 3023 CONFIDENCE standard compound; INTERNAL_ID 1559 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
zofenoprilat
C15H19NO3S2 (325.08063039999996)
A proline derivative that is 4-(phenylsulfanyl)-L-proline in which the amine proton is replaced by a (2S)-2-methyl-3-sulfanylpropanoyl group. The active metabolite of zofenopril. C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor
Diniconazole
C15H17Cl2N3O (325.07486120000004)
C254 - Anti-Infective Agent > C514 - Antifungal Agent CONFIDENCE standard compound; INTERNAL_ID 831; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10020; ORIGINAL_PRECURSOR_SCAN_NO 10019 CONFIDENCE standard compound; INTERNAL_ID 831; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10120; ORIGINAL_PRECURSOR_SCAN_NO 10118 CONFIDENCE standard compound; INTERNAL_ID 831; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10087; ORIGINAL_PRECURSOR_SCAN_NO 10086 CONFIDENCE standard compound; INTERNAL_ID 831; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10071; ORIGINAL_PRECURSOR_SCAN_NO 10069 CONFIDENCE standard compound; INTERNAL_ID 831; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10044; ORIGINAL_PRECURSOR_SCAN_NO 10043 CONFIDENCE standard compound; INTERNAL_ID 831; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10088; ORIGINAL_PRECURSOR_SCAN_NO 10086
Alendronate sodium
C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
Urothion
Urothion is a normal molybdenum cofactor metabolite, a yellowish sulfur-containing pteridine derivative isolated from human urine. It is optically active with one chiral center (PMID: 8690716). Urothion is deficient in patients with molybdenum cofactor deficiency (PMID: 6960353) [HMDB] Urothion is a normal molybdenum cofactor metabolite, a yellowish sulfur-containing pteridine derivative isolated from human urine. It is optically active with one chiral center (PMID: 8690716). Urothion is deficient in patients with molybdenum cofactor deficiency (PMID: 6960353).
Avenanthramide L
Avenanthramide L is found in cereals and cereal products. Avenanthramide L is isolated from oat, Avena sativa, inoculated with Puccinia coronata f. sp. avenae. Isolated from oat, Avena sativa, inoculated with Puccinia coronata f.species avenae. Avenanthramide L is found in oat and cereals and cereal products.
Dihyroxy-1H-indole glucuronide I
Dihyroxy-1H-indole glucuronide I is a conjugate of dihyroxy-1H-indole and glucuronide I. A glucuronide, also known as glucuronoside, is any substance produced by linking glucuronic acid to another substance via a glycosidic bond. The glucuronides belong to the glycosides. (Wikipedia)
NeuNGc
NeuNGc, also known as N-Glycolylneuraminic acid or Neu5GC, is classified as a member of the N-acylneuraminic acids. N-acylneuraminic acids are neuraminic acids carrying an N-acyl substituent. NeuNGc is considered to be soluble (in water) and acidic
(2R,4R,5S,6S)-2,4-Dihydroxy-5-[(2-hydroxyacetyl)amino]-6-[(1S,2S)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Isolated from beef serum
7-Acetamidoflunitrazepam
Basimglurant
C18H13ClFN3 (325.07819800000004)
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent Basimglurant (RG7090) is a potent, selective and orally available mGlu5 negative allosteric modulator with a Kd of 1.1 nM[1]. Basimglurant is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
[4-Amino-2-(4-methoxyanilino)-1,3-thiazol-5-yl]-phenylmethanone
Diniconazole
C15H17Cl2N3O (325.07486120000004)
Hexyl 2,5-dichlorophenylphosphoroamidate
C12H18Cl2NO3P (325.04013080000004)
isoxazolyl penicillin
o6-Carboxymethyl-2'-deoxy-guanosine
2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide
2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate
2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate belongs to tricarboxylic acids and derivatives class of compounds. Those are carboxylic acids containing exactly three carboxyl groups. 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate is slightly soluble (in water) and a weakly acidic compound (based on its pKa). 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate can be found in a number of food items such as feijoa, german camomile, sugar apple, and rapini, which makes 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate a potential biomarker for the consumption of these food products.
Asparagine-betaxanthin
N-[3-(1-Methyl-2-amino-1H-imidazole-5-yl)propyl]-4-bromo-1H-pyrrole-2-carboxamide
costinone B|methyl 4-hydroxy-3-{3-[(E)-methoxymethylidene]-2-oxo-2,3-dihydro-1H-indol-1-yl}benzoate
Benzyl glycoside,N-Ac-alpha-D-pyranose-2-Amino-2-deoxymannuronic acid
1,9-Dimethoxy-2-hydroxy-3-(hydroxymethyl)-5-azaacephenanthrylene-4(5H)-one
[5-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl acetate
(4-hydroxy-3-methoxyphenyl)acetonitrile 4-O-beta-D-glucopyranoside|4-hydroxy-3-methoxyphenylacetonitrile 4-O-beta-D-glucopyranoside|adenophoraside A|hydranitriloside B1|[4-(beta-D-glucopyranosyloxy)-3-methoxyphenyl]acetonitrile
(3-hydroxy-4-methoxyphenyl)acetonitrile 3-O-beta-D-glucopyranoside|hydranitriloside A2|[3-(beta-D-glucopyranosyloxy)-4-methoxyphenyl]acetonitrile
desulfo-4-(methylsulfanyl)butyl GL|desulfoglucoerucin|DS-GER
C12H23NO5S2 (325.10175879999997)
2-cyano-3-hydroxy-4-methylbenzenemethanol-7-O-beta-D-glucopyranoside|crenulatanoside A
4-Amino-1-(O5-phosphono-beta-D-ribofuranosyl)-5,6-dihydro-1H-pyrimidin-2-on|4-amino-1-(O5-phosphono-beta-D-ribofuranosyl)-5,6-dihydro-1H-pyrimidin-2-one
2,3-Dihydro-2,6-dihydroxy-3,3-dimethyl-1H-pyrano[2,3-c]acridine-1,7(12H)-dione
midazolam
C18H13ClFN3 (325.07819800000004)
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
GSK232420A
CONFIDENCE standard compound; INTERNAL_ID 819; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4045; ORIGINAL_PRECURSOR_SCAN_NO 4040 CONFIDENCE standard compound; INTERNAL_ID 819; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4069; ORIGINAL_PRECURSOR_SCAN_NO 4064 CONFIDENCE standard compound; INTERNAL_ID 819; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4044; ORIGINAL_PRECURSOR_SCAN_NO 4041 CONFIDENCE standard compound; INTERNAL_ID 819; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4047; ORIGINAL_PRECURSOR_SCAN_NO 4043 CONFIDENCE standard compound; INTERNAL_ID 819; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4075; ORIGINAL_PRECURSOR_SCAN_NO 4070 CONFIDENCE standard compound; INTERNAL_ID 819; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4077; ORIGINAL_PRECURSOR_SCAN_NO 4072
Citalopram (propionic acid derivative)
C19H16FNO3 (325.11141580000003)
4,6-dimethyl-2-[(4-nitrophenyl)methylsulfanyl]quinazoline
4-(3-Chloro-phenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-carboxylic acid
Diniconazole M
C15H17Cl2N3O (325.07486120000004)
C254 - Anti-Infective Agent > C514 - Antifungal Agent
Piperazine, 1-[(3-chloro-6-nitrobenzo[b]thien-2-yl)carbonyl]- (9CI)
2-nitroso-1-naphthol-4-sulfonic acid tetrahydrate
C10H15NO9S (325.04675000000003)
N-BOC-BELTA-ALANINE-BELTA-2-CHLOROPHENYL-N-CARBOXYANHYDRIDE
2-[2-(trifluoromethyl)phenothiazin-10-yl]acetic acid
3-AMINO-3-(3-[3-(TRIFLUOROMETHYL)PHENOXY]PHENYL)PROPANOIC ACID
n-([3-(trifluoromethyl)phenyl]sulfonyl)valine
C12H14F3NO4S (325.05956000000003)
(S)-3-(Methylthio)pyrrolidine-3-carboxylic acid Methyl ester L-tartarate
2,3-dimethylnaphtho[1,2-d]thiazolium methylsulfate
2,4-Dichlorophenoxyacetic acid diethanolamine salt
(4-(N-(4-Fluoro-3-methoxyphenyl)sulfamoyl)phenyl)boronic acid
C13H13BFNO5S (325.05914900000005)
(11ar)-(+)-10,11,12,13-tetrahydrodiindeno[7,1-de:1,7-fg][1,3,2]dioxaphosphocin-5-dimethylamine
C19H20NO2P (325.12315900000004)
TRANS-1-(TERT-BUTOXYCARBONYL)-4-(4-CHLOROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID
C16H20ClNO4 (325.10807900000003)
3-Iodomethyl-piperidine-1-carboxylic acid tert-butyl ester
Boc-trans-DL-b-Pro-4-(4-chlorophenyl)-OH
C16H20ClNO4 (325.10807900000003)
1,3-bis(3,3,3-trifluoropropyl)tetramethyldisilazane
C10H21F6NSi2 (325.11166579999997)
Ethanol,2-[(4-amino-5-methoxy-2-methylphenyl)sulfonyl]-, 1-(hydrogen sulfate)
C10H15NO7S2 (325.02899199999996)
[(Oxido)phenyl(trifluoromethyl)-lambda4-sulfanylidene]dimethylammonium Tetrafluoroborate
C9H11BF7NOS (325.05425900000006)
2H-1,4-Benzodiazepin-2-one,1,3-dihydro-1-(methoxymethyl)-7-nitro-5-phenyl-
C17H15N3O4 (325.10625100000004)
2H-Isoindole-2-aceticacid, 1,3-dihydro-a-[(4-methoxyphenyl)methyl]-1,3-dioxo-, (S)- (9CI)
4-(3-chlorophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid
C16H20ClNO4 (325.10807900000003)
N-(4-Bromobenzoyl)-4-methylpiperazine-1-carboxamide
tert-Butyl (1-(4-bromophenyl)cyclobutyl)carbamate
C15H20BrNO2 (325.06773200000003)
Ethyl 5-hydroxy-8-methyl-7-oxo-2-phenyl-7,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylate
C17H15N3O4 (325.10625100000004)
TERT-BUTYL 7-BROMO-4-OXO-3,4-DIHYDROQUINOLINE-1(2H)-CARBOXYLATE
5-[N-(3,5-BISTRIFLUOROMETHYLBENZYL)AMINO]-2-METHYLTETRAZOLE
C11H9F6N5 (325.07621059999997)
N-METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE
C16H20ClNO4 (325.10807900000003)
2-amino-N-[2-[(4-methyl-2-oxochromen-7-yl)amino]-2-oxoethyl]acetamide,hydrochloride
4-bromo-N-cyclohexyl-2-ethoxybenzamide
C15H20BrNO2 (325.06773200000003)
2-formylphenyl 2-acetamido-2-deoxy-beta-d-glucopyranoside
Chlophedianol Hydrochloride
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent
N-[(4-CHLORO-PHENYL)-(2-HYDROXY-NAPHTHALEN-1-YL)-METHYL]-ACETAMIDE
1-Pyrrolidinecarboxylic acid, 2-(4-bromophenyl)-, 1,1-dimethylethyl ester, (2R)-
C15H20BrNO2 (325.06773200000003)
4-Nitrophenyl 2-(2-tert-butoxy-2-oxoethyl)-2-Methylhydrazinecarboxylate
(2E)-1-(8-Bromo-3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-3-(dimethylamino)prop-2-en-1-one
(4-(N-(3-CHLORO-2-METHYLPHENYL)SULFAMOYL)PHENYL)BORONIC ACID
C13H13BClNO4S (325.03468380000004)
(4,5-DIHYDRO-THIAZOL-2-YL)-[2-(4-METHOXY-PHENYL)-ETHYL]-AMINE
C16H15N5OS (325.09972600000003)
Boronic acid, B-[4-[[[4-(trifluoromethoxy)phenyl]amino]carbonyl]phenyl]-
C14H11BF3NO4 (325.07331920000007)
(1-[2-(4-FLUORO-PHENYL)-ETHYL]-1H-PYRROL-2-YL)-METHANOL
C19H20NO2P (325.12315900000004)
benzyl 4-(2-bromoethyl)piperidine-1-carboxylate
C15H20BrNO2 (325.06773200000003)
2-(TRIPHENYLPHOSPHONIO)ETHYL CHLORO-
C20H19ClP+ (325.09128340000007)
Chloropyramine hydrochloride
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Chloropyramine hydrochloride is a histamine receptor H1 antagonist which can also inhibit the biochemical function of VEGFR-3 and FAK.
tert-butyl 2-(4-bromophenyl)pyrrolidine-1-carboxylate
C15H20BrNO2 (325.06773200000003)
Methanone, [4-amino-2-(ethylthio)-5-pyrimidinyl](2,3-difluoro-6-Methoxyphenyl)-
4-Amino-5-benzoyl-2-(4-methoxyphenylamino)thiazole
Theophylline, 8-(2-pyrrolidinoethyl)thio-6-thio-
C13H19N5OS2 (325.10309639999997)
3-(2-Methoxyphenyl)-6-(3-nitrophenyl)-1,4-dihydropyrimidin-2-one
C17H15N3O4 (325.10625100000004)
1-(2,3-Dihydro-1,4-benzodioxin-3-ylmethyl)-5-methoxyindole-2,3-dione
5-[(3-ethoxycarbonyl-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl)amino]-5-oxopentanoic acid
C15H19NO5S (325.09838840000003)
3-[5-(dimethylsulfamoyl)-1-ethyl-1H-1,3-benzodiazol-2-yl]propanoic acid
C14H19N3O4S (325.10962140000004)
2-(2-imidazo[1,2-a]pyridinylmethylthio)-6-nitro-1H-benzimidazole
N2-(4-methylphenyl)-6-[(2-pyrimidinylthio)methyl]-1,3,5-triazine-2,4-diamine
C15H15N7S (325.11095900000004)
2-[(4-Chloroanilino)methylidene]-5-phenylcyclohexane-1,3-dione
2-chloro-N-[3-(4-methylphenyl)-1-phenyl-4-pyrazolyl]acetamide
2-[[6-(2-furanyl)-3-pyridazinyl]thio]-N-(3-methylphenyl)acetamide
(E)-2-cyano-N-(3-imidazol-1-ylpropyl)-3-(4-nitrophenyl)prop-2-enamide
2-chloro-N-(2-ethyl-4-oxo-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-3-yl)acetamide
2-(Anilinomethylidene)-5-(3-chlorophenyl)cyclohexane-1,3-dione
(R)-(+) 5(9BH)-Oxo-9B-phenyl-2,3-dihydrothiazolo[2,3-A]isoindol-3-carboxylic acid methyl ester
Basimglurant
C18H13ClFN3 (325.07819800000004)
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent Basimglurant (RG7090) is a potent, selective and orally available mGlu5 negative allosteric modulator with a Kd of 1.1 nM[1]. Basimglurant is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
3-amino-N-[3-(triluoromethyl)benzoyl]pyrazine-2-carbohydrazide
(2,2-Dimethyl-5-phenylimino-1,3,4-thiadiazolidin-3-yl)-(2-methylphenyl)methanone
6,7-dimethyl-8-(1-D-ribityl)lumazine(1-)
The anion formed from 6,7-dimethyl-8-(1-D-ribityl)lumazine by removal of a proton from the nitrogen at position 3 (i.e. between the oxo groups). It is the major species at physiological pH.
(E)-2-methylgeranyl diphosphate(3-)
C11H19O7P2-3 (325.06059839999995)
4-O-beta-D-Glucosyl-4-hydroxycinnamate
C15H17O8- (325.09233820000003)
trans-beta-D-Glucosyl-2-hydroxycinnamate
C15H17O8- (325.09233820000003)
4-O-beta-D-Glucosyl-cis-p-coumarate
C15H17O8- (325.09233820000003)
2-(beta-D-glucosyloxy)-cis-cinnamate
C15H17O8- (325.09233820000003)
2-succinyl-5-enolpyruvoyl-6-hydroxy-3-cyclohexene-1-carboxylate
2-Amino-4-[5-(2-amino-2-carboxylatoethyl)-2-hydroxyphenyl]pentanedioate
C14H17N2O7- (325.10357120000003)
2-Amino-4-[3-(2-amino-2-carboxylatoethyl)-6-oxocyclohexa-1,4-dien-1-yl]pentanedioate
C14H17N2O7- (325.10357120000003)
2-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-oxo-3H-pyrrolo[2,3-d]pyrimidine-5-carboxylate
[amino-[2-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl]methylidene]azanium
C12H17N6O5+ (325.12603720000004)
5-(1-Carboxylatoethenoxy)-2-(3-carboxylatopropanoyl)-6-hydroxycyclohex-2-ene-1-carboxylate
3-Amino-4-(4-chlorophenyl)-6-cyclopropyl-2-thieno[2,3-b]pyridinecarbonitrile
C17H12ClN3S (325.04404220000004)
12-phenyl-12H-benzo[5,6]chromeno[2,3-d]pyrimidin-11-amine
2-[(3-methyl-4-oxo-2-quinazolinyl)thio]-N-phenylacetamide
6-Chloro-n2-cyclopentyl-n4-(3,5-difluorophenyl)-1,3,5-triazine-2,4-diamine
3-(1,3-benzodioxol-5-yl)-4-(2,5-dimethylphenyl)-1H-1,2,4-triazole-5-thione
N-[[3-chloro-2-(1-pyrrolidinyl)anilino]-sulfanylidenemethyl]butanamide
2-(1H-benzimidazol-2-ylthio)-1-(2,5-dimethyl-1-prop-2-enyl-3-pyrrolyl)ethanone
3-(4-Chlorophenyl)-2-(1-pyrrolidinyl)-4-quinazolinone
2-(1,3-dioxo-2-isoindolyl)-N-(3-nitrophenyl)acetamide
3-(1,3-Benzothiazol-2-yl)propanoic acid phenacyl ester
3-(3-Benzo[1,3]dioxol-5-yl-acryloylamino)-benzoic acid methyl ester
5-(3,4-dimethoxyphenyl)-N-(3-pyridinyl)-3-isoxazolecarboxamide
C17H15N3O4 (325.10625100000004)
8-Nitro-5-[3-(trifluoromethyl)-1-piperidinyl]isoquinoline
2-[(1-methyl-5-tetrazolyl)thio]-N-(2-phenylphenyl)acetamide
C16H15N5OS (325.09972600000003)
1-(4-Methyl-2-oxo-1-benzopyran-7-yl)-3-(2-pyridinylmethyl)thiourea
(5Z)-2-(2-furyl)-5-(2-methoxybenzylidene)[1,3]thiazolo[3,2-b][1,2,4]triazol-6(5H)-one
4-{(2E)-2-[(2-chloroquinolin-3-yl)methylidene]hydrazinyl}benzoic acid
(1R,2S,5S,6S)-2-(3-carboxylatopropanoyl)-5-[(1-carboxylatovinyl)oxy]-6-hydroxycyclohex-3-ene-1-carboxylate
2-[(4Z)-4-(furan-2-ylmethylidene)-2,5-dioxoimidazolidin-1-yl]-N-(4-methylphenyl)acetamide
C17H15N3O4 (325.10625100000004)
(4-methylphenyl)(2-sulfanylidene[1,2,4]triazolo[5,1-b][1,3]benzothiazol-1(2H)-yl)methanone
2-(2-imino-3-thiazolyl)-N-(2-phenoxyphenyl)acetamide
(4-Methyl-1-piperazinyl)-(6-methyl-2-thieno[2,3-b]quinolinyl)methanone
1,3-Benzodioxol-5-yl 2-methyl-6-(trifluoromethyl)nicotinate
C15H10F3NO4 (325.05618960000004)
4-(Phenylmethyl)-1-(4-thieno[2,3-d]pyrimidinyl)-4-piperidinol
(2R,3R,4S)-2-cyano-N-(3-fluorophenyl)-4-(hydroxymethyl)-3-phenylazetidine-1-carboxamide
(2S,3S,4R)-2-cyano-N-(3-fluorophenyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinecarboxamide
(2R,3S,4R)-2-cyano-N-(3-fluorophenyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinecarboxamide
(2R,3S,4S)-2-cyano-N-(3-fluorophenyl)-4-(hydroxymethyl)-3-phenylazetidine-1-carboxamide
(2S,3R,4R)-2-cyano-N-(3-fluorophenyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinecarboxamide
(2S,3S,4S)-2-cyano-N-(3-fluorophenyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinecarboxamide
(2R,3R,4R)-2-cyano-N-(3-fluorophenyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinecarboxamide
sodium (allyl 7-azido-3,7-dideoxy-beta-L-gulo-oct-2-ulopyranosid)onate
3-[(6-acetyl-3,4,5-trihydroxyoxan-2-yl)oxy]-3a,4,7,7a-tetrahydro-1H-isoindol-1-one
ethyl 4-[2-[(E)-(2,5-dioxoimidazolidin-4-ylidene)methyl]pyrrol-1-yl]benzoate
C17H15N3O4 (325.10625100000004)
(2S,4E)-4-[2-[(2S,4R)-2-carboxy-4-hydroxypyrrolidin-1-ium-1-ylidene]ethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylic acid
C14H17N2O7+ (325.10357120000003)
(2S)-2-phenoxy-N-(4-pyridin-2-yl-1,3-thiazol-2-yl)propanamide
5,7-Dimethyl-3-hydroxyimino-34-methylenedoxyflavanone
N-glycoloyl-beta-neuraminic acid
An N-acylneuraminic acid in which the acyl substituent on nitrogen is glycolyl and which has beta-configuration at the anomeric centre.
(1R,2S,5S,6S)-2-(3-carboxylatopropanoyl)-5-[(1-carboxylatovinyl)oxy]-6-hydroxycyclohex-3-ene-1-carboxylate
Tricarboxylate anion of (1R,2S,5S,6S)-2-(3-carboxypropanoyl)-5-[(1-carboxyvinyl)oxy]-6-hydroxycyclohex-3-ene-1-carboxylic acid.
N-glycoloyl-alpha-neuraminic acid
An N-acylneuraminic acid in which the acyl substituent on nitrogen is glycoloyl and which has alpha-configuration at the anomeric centre.
4-O-beta-D-glucosyl-trans-4-coumarate
A 4-O-beta-D-glucosyl-4-coumarate in which the double bond has trans-configuration.
Auglurant
Auglurant (VU0424238) is a novel and selective mGlu5 antagonist with an IC50 value of 11 nM (rat) and an IC50 value of 14 nM (human). Auglurant (VU0424238) has an acceptable CNS penetration[1].